Search results
Hans Clevers. Johannes (Hans) Carolus Clevers (born 27 March 1957) [3] [4] is a Dutch molecular geneticist, cell biologist and stem cell researcher. He became the Head of Pharma, Research and Early Development, and a member of the Corporate Executive Committee, of the Swiss healthcare company Roche in 2022.
- 2
- Eefke Petersen
- Dutch
- University of Utrecht
Hans Clevers is a renowned scientist who studies Wnt signaling, stem cells and organoids. He is the Head of pRED at Roche, Basel, and an advisor/guest researcher at the Hubrecht Institute, where he leads the Organoid group.
1997. Wnt signalling in stem cells and cancer. T Reya, H Clevers. Nature 434 (7035), 843-850. , 2005. 4737. 2005. Constitutive transcriptional activation by a β-catenin-Tcf complex in APC−/− colon carcinoma. V Korinek, N Barker, PJ Morin, D Van Wichen, R De Weger, KW Kinzler, ...
Hans Clevers is a Distinguished Professor at Utrecht University and guest scientist/advisor at the Hubrecht Institute (KNAW). He is also guest scientist/advisor of the Princess Máxima Center for pediatric oncology and Oncode Investigator. Hans Clevers's stem-cell research plays a prominent role within the Utrecht strategic research theme Life ...
Since 2002 University of Utrecht, Professor in Molecular Genetics. 2002–2022 Hubrecht Institute, Utrecht, (continued as advisor beyond March 2022), Principal Investigator of a research group of ~25 scientists. 2012–2015 Royal Netherlands Academy of Sciences, Utrecht, President. 2015–2019 Princess Máxima Center for Pediatric Oncology ...
Hans Clevers runs a research group at the Hubrecht Institute for Developmental Biology and Stem Cell Research of the Royal Dutch Academy of Arts and Sciences. He is also the Director of Research ...
People also ask
What does Hans Clevers do?
Who is Hans Clevers (q1579050)?
Why did Hans Clevers get a PhD?
Where did Clevers go after a PhD?
May 13, 2024 · Hans Clevers Present address: Pharma Research and Early Development (pRED) of F. Hoffmann-La Roche Ltd, Basel, Switzerland These authors contributed equally: Delilah Hendriks, Benedetta Artegiani.
